Cargando…
Patient involvement in selection of immunosuppressive regimen following transplantation
Transplantation has made a considerable difference to the lives of many patients. However, feedback from patients indicates that although having a transplant is a hugely positive experience, having to take medications indefinitely is one of the biggest challenges. An ideal scenario would be no medic...
Autores principales: | Popoola, Joyce, Greene, Helen, Kyegombe, Margaret, MacPhee, Iain A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4270302/ https://www.ncbi.nlm.nih.gov/pubmed/25525347 http://dx.doi.org/10.2147/PPA.S38987 |
Ejemplares similares
-
Individualized immunosuppression in transplant patients: potential role of pharmacogenetics
por: Abboudi, Hamid, et al.
Publicado: (2012) -
Immunological risk stratification and tailored minimisation of immunosuppression in renal transplant recipients
por: Phanish, Mysore K., et al.
Publicado: (2020) -
Limited sampling strategies for estimation of tacrolimus exposure in kidney transplant recipients receiving extended‐release tacrolimus preparation
por: El‐Nahhas, Toqa, et al.
Publicado: (2021) -
Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients
por: Locke, Jayme E, et al.
Publicado: (2011) -
Transplantation: Polyomavirus Nephropathy and the Risk of Specific Immunosuppression Regimens
por: Wu, Christine, et al.
Publicado: (2006)